• September 27, 2021 Ophthalmic VEGF Inhibitor Acquisition of Marketing Approval for “Ranibizumab BS Intravitreal Injection Kit 10 mg/mL ‘Senju’”（PDF）
• December 9, 2019 Senju and Otsuka Launch a New Treatment for Glaucoma and Ocular Hypertension - AIBETA® Combination Ophthalmic Solution（PDF）
• December 25, 2018 Launch of Neuroptika, Inc.（PDF）
• September 14, 2016 Announcement of co-promotion of new glaucoma treatment（PDF）
• June 11, 2014 License Agreement to Development and Commercialize Azithromycin Ophthalmic Solution Using DuraSite® in Japan
• May 29, 2013 Collaboration License Agreement for the Development and Commercialization of Integrin Peptide Therapy
• April 20, 2012 To be released on May 11, 2012: “AIPHAGAN® Ophthalmic Solution 0.1%”for the treatment of Glaucoma / Ocular Hypertension （PDF）
• November 17, 2009 The approval of 『BRONUCK ®』　（bromfenac sodium hydrate ophthalmic solution）as an import drug in China（PDF）
• October 1, 2009 To be released on October 5, 2009:『LUMIGAN®Ophthalmic Solution 0.03%』for the treatment of Glaucoma / Ocular Hypertension
• July 8, 2009 Marketing Approval of 『LUMIGAN Ophthalmic Solution 0.03%』 as a treatment for Glaucoma / Ocular Hypertension